Ticker Details
Castle Biosciences, Inc.
IPO Date:	July 22, 2019
Sector:	Healthcare
Market Cap:	$806.31M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.98 | 2.94%
Avg Daily Range (30 D):	$0.81 | 2.34%
Avg Daily Range (90 D):	$0.69 | 2.01%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.37M
Avg Daily Volume (90 D):	.35M

Trade Size
Avg Trade Size (Sh.):	56
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	1,455
Avg Institutional Trade:	$1.34M
Avg Institutional Trade (30 D):	$2.17M
Avg Institutional Trade (90 D):	$1.89M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.45M
Avg Closing Trade (30 D):	$2.31M
Avg Closing Trade (90 D):	$2.12M
Avg Closing Volume:	47.05K

News

Mar 9, 2026 @ 11:00 AM DecisionDx®-Melanoma’s i31-SLNB: Report ... Source: Castle Biosciences, Inc.

Feb 19, 2026 @ 10:46 PM Prospective Validation Study in JAAD Demonstrates ... Source: Castle Biosciences, Inc.

Dec 12, 2025 @ 12:00 PM Systematic Review and Meta-Analysis Confirms Tissu... Source: Caitlin C. Houghton, M.D.

Nov 17, 2025 @ 12:00 PM Castle Biosciences Earns a Houston Chronicle Top W... Source: Derek Maetzold

Nov 11, 2025 @ 12:00 PM Castle Biosciences to Present at the Piper Sandler... Source: Castle Biosciences Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.83	$-.07	$-.83
Diluted EPS	$-.83	$-.07	$-.83
Revenue	$344.23M	$87.01M	$344.23M
Gross Profit	$273.2M	$68.7M	$273.2M
Net Income / Loss	$-24.16M	$-2.33M	$-24.16M
Operating Income / Loss	$-42.81M	$-3.83M	$-42.81M
Cost of Revenue	$71.03M	$18.32M	$71.03M
Net Cash Flow	$-2.98M	$31.17M	$-2.98M
PE Ratio